Li M1, Jin L2, Lu Z2, Bai X1, Jiang B1, Song Y1, Chen L3, Dai X3 and Wang Y1*
1General Hospital of Ningxia Medical University, China 2Ningxia Medical University, China 3Union Hospital Affiliated to Fujian Medical University, ChinaFulltext PDF
On October 01st, 2022, our hospital successfully implanted a left ventricular assist device (artificial heart) in a patient with dilated cardiomyopathy. The patient recovered well after the operation and was discharged successfully on the 9th day after the operation. After discharge, the patient received lifelong anticoagulant treatment with aspirin and warfarin, reviewed the blood coagulation function regularly, adjusted the amount of warfarin according to the blood coagulation situation, so that the INR was always maintained between 2.0 and 3.0, and came to our hospital's outpatient clinic for review regularly. The operation of the left ventricular assist device (artificial heart) was evaluated, and the medication was adjusted according to the condition.
Left ventricular assist device; Artificial heart Dilated cardiomyopathy
Li M, Jin L, Lu Z, Bai X, Jiang B, Song Y, et al. The First Case of Left Ventricular Assist Device Implantation (Artificial Heart) in Ningxia. Ann Clin Surg. 2023; 4(1): 1027.